Efficacy, tolerability and safety of Z7202, a once daily Diclofenac Diethylamine (DEA) medicated plaster in comparison with Flector, a twice daily Diclofenac Hydroxyethylpyrrolidine medicated plaster in the local treatment of post-traumatic painful conditions.

Trial Profile

Efficacy, tolerability and safety of Z7202, a once daily Diclofenac Diethylamine (DEA) medicated plaster in comparison with Flector, a twice daily Diclofenac Hydroxyethylpyrrolidine medicated plaster in the local treatment of post-traumatic painful conditions.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2017

At a glance

  • Drugs Diclofenac diethylammonium; Diclofenac hydroxyethylpyrrolidine
  • Indications Acute pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Mar 2012 Actual end date (9 Dec 2011) added as reported by European Clinical Trials Database.
    • 23 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
    • 23 Mar 2012 Actual initiation date changed from 18 Jan 2011 to 9 Feb 2011 as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top